PROFILE OF ANTIBODIES AGAINST EPSTEIN-BARR VIRUS IN PATIENTS WITH BLOOD DISORDERS

被引:0
|
作者
Zuk-Wasek, Anna [1 ]
Litwinska, Bogumila [1 ]
Traczyk, Zdzislawa [2 ]
机构
[1] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Virol, PL-00791 Warsaw, Poland
[2] Inst Haematol & Transfusiol, Dept Internal Dis, PL-02776 Warsaw, Poland
关键词
humans; Epstein-Barr virus; antibodies; blood disorders;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to investigate the profile of Epstein-Barr virus (EBV) antibodies and to compare this profile with the detectability of EBV DNA and compare this profile in healthy people with the profile in patients with blood disorders. The profile of antibodies was examined in serum from the following groups: 40 patients with blood disorders, but without EBV DNA in their lymphocytes, 44 patients with blood disorders and EBV DNA in lymphocytes, and 46 healthy people. EBV antibodies were detected by using ELISA commercial kits. The obtained results were analysed by Fisher's exact test. No significant differences in antibody profiles were found between EBV DNA-positive and EBV DNA-negative sera. Between patients and the control group, considerable differences were observed in reactivation and in past infection, and a significant difference was observed in chronic infection. These analyses suggest that EBV reactivation or chronic infection can be related with blood disorders and have an influence on the course of blood disorders.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 50 条
  • [21] Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus
    Mary L. Huggins
    Ian Todd
    Richard J. Powell
    Rheumatology International, 2005, 25 : 183 - 187
  • [22] Indirect measurement of Epstein-Barr virus neutralising antibodies by ELISA
    Wilson, AD
    Morgan, AJ
    JOURNAL OF VIROLOGICAL METHODS, 1998, 73 (01) : 11 - 19
  • [23] Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus
    Huggins, ML
    Todd, I
    Powell, RJ
    RHEUMATOLOGY INTERNATIONAL, 2005, 25 (03) : 183 - 187
  • [24] Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection
    Bauer, CC
    Aberle, SW
    Popow-Kraupp, T
    Kapitan, M
    Hofmann, H
    Puchhammer-Stöckl, E
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (01) : 54 - 58
  • [25] A microelectrochemical sensing system for the determination of Epstein-Barr virus antibodies
    Bandilla, Michael
    Zimdars, Andreas
    Neugebauer, Sebastian
    Motz, Manfred
    Schuhmann, Wolfgang
    Hartwich, Gerhard
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 398 (06) : 2617 - 2623
  • [26] Effect of infection on lipid profile: focus on Epstein-Barr virus
    Gazi, Irene F.
    Elisaf, Moses S.
    CLINICAL LIPIDOLOGY, 2010, 5 (05) : 607 - 610
  • [27] Post-transplantation lymphoproliferative disorders and Epstein-Barr virus
    Caillard, S
    Heibel, F
    Benaicha, M
    Moulin, B
    NEPHROLOGIE, 1998, 19 (08): : 481 - 488
  • [28] Epstein-Barr virus in tumours
    Anagnostopoulos, I
    Hummel, M
    HISTOPATHOLOGY, 1996, 29 (04) : 297 - 315
  • [29] Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection
    Nakai, Hidetaka
    Kawamura, Yoshiki
    Sugata, Ken
    Sugiyama, Hiroko
    Enomoto, Yoshihiko
    Asano, Yoshizo
    Ihira, Masaru
    Ohashi, Masahiro
    Kato, Tomochika
    Yoshikawa, Tetsushi
    MICROBIOLOGY AND IMMUNOLOGY, 2012, 56 (02) : 93 - 98
  • [30] Epstein-Barr virus-related lymphoproliferative disorders of the skin
    Ferrara, Gerardo
    Gualandi, Alberto
    DERMATOLOGY REPORTS, 2024, 16